MarketCap
Facebook
X
Telegram
Land |
 Deuschland |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
122 M |
Marktkapitalisierung |
$ 946 M |
EBITDA (LTM) |
$ -300 M |
P/E (LTM) |
-5.42 |
P/S (LTM) |
- |
EPS (LTM) |
-2.1 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
InflaRx N.V.
IFRX
|
$ 1.68 | 0.58 % | $ 113 M | Nasdaq Global Select Market | Germany |
 |
Immutep Limited
IMMP
|
$ 4.27 | 0.46 % | $ 6.22 B | Nasdaq Global Market |  Australia |
 |
Immunome
IMNM
|
$ 21.17 | 1.29 % | $ 1.85 B | Nasdaq Global Select Market |  USA |
 |
Immuron Limited
IMRN
|
$ 1.07 | 0.46 % | $ 247 M | Nasdaq Global Select Market | Australia |
 |
Immunic
IMUX
|
$ 8.07 | 1.38 % | $ 1.26 B | Nasdaq Global Select Market | USA |
 |
Immunovant
IMVT
|
$ 33.25 | 0.18 % | $ 6.07 B | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.58 | 1.28 % | $ 142 M | Nasdaq Global Select Market |  France |
 |
Incyte Corporation
INCY
|
$ 114.13 | 0.06 % | $ 22.3 B | Nasdaq Global Select Market,SPB | USA |
 |
InMed Pharmaceuticals
INM
|
$ 1.33 | 0.01 % | $ 5.54 M | Nasdaq Capital Market |  Canada |
 |
INmune Bio
INMB
|
$ 1.94 | 0.52 % | $ 48 M | Nasdaq Capital Market | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.15 | 2.05 % | $ 53.9 M | Nasdaq Global Select Market | USA |
 |
Insmed Incorporated
INSM
|
$ 103.83 | 2.33 % | $ 20.7 B | Nasdaq Global Select Market | USA |
 |
Innoviva
INVA
|
$ 20.64 | 0.68 % | $ 1.39 B | Nasdaq Global Select Market | USA |
 |
Iovance Biotherapeutics
IOVA
|
$ 14.15 | 0.63 % | $ 5.06 M | Nasdaq Global Market,SPB | USA |
 |
Ironwood Pharmaceuticals
IRWD
|
$ 3.65 | 0.27 % | $ 591 M | Nasdaq Global Select Market | USA |
 |
Inventiva S.A.
IVA
|
$ 3.48 | 2.89 % | $ 208 M | Nasdaq Global Market | France |
 |
Jaguar Health
JAGX
|
$ 4.73 | 29.23 % | $ 11 M | Nasdaq Capital Market | USA |
 |
Jazz Pharmaceuticals plc
JAZZ
|
$ 236.04 | 0.16 % | $ 14.4 B | Nasdaq Global Select Market |  Irlanda |
 |
Johnson & Johnson
JNJ
|
$ 252.93 | 0.03 % | $ 609 B | NYSE,SPB | USA |
 |
Kala Pharmaceuticals
KALA
|
$ 0.36 | 0.86 % | $ 2.93 M | Nasdaq Global Select Market | USA |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 76.31 | 0.69 % | $ 5.66 B | Nasdaq Global Select Market | USA |
 |
Kodiak Sciences
KOD
|
$ 93.81 | 0.32 % | $ 4.99 B | Nasdaq Global Market,SPB | USA |
 |
Karyopharm Therapeutics
KPTI
|
$ 0.67 | 1.51 % | $ 7.33 K | Nasdaq Global Select Market | USA |
 |
Keros Therapeutics
KROS
|
$ 11.52 | 1.41 % | $ 429 M | Nasdaq Global Select Market | USA |
 |
Krystal Biotech
KRYS
|
$ 334.85 | 3.9 % | $ 9.69 B | Nasdaq Global Market,SPB | USA |
 |
Kura Oncology
KURA
|
$ 10.62 | 0.09 % | $ 931 M | Nasdaq Global Select Market | USA |
 |
Kymera Therapeutics
KYMR
|
$ 109.85 | 2.29 % | $ 9.28 B | Nasdaq Global Market | USA |
 |
Kazia Therapeutics Limited
KZIA
|
$ 9.35 | 0.86 % | $ 143 M | Nasdaq Global Select Market | Australia |
 |
Lineage Cell Therapeutics
LCTX
|
$ 0.93 | 2.73 % | $ 214 M | NYSE American | USA |
 |
Legend Biotech Corporation
LEGN
|
$ 18.77 | 1.1 % | $ 6.92 B | Nasdaq Global Select Market | USA |
 |
Ligand Pharmaceuticals Incorporated
LGND
|
$ 306.77 | 1.26 % | $ 5.93 B | Nasdaq Global Select Market,SPB | USA |
 |
Longeveron
LGVN
|
$ 2.51 | 0.39 % | $ 44.1 B | Nasdaq Global Select Market | USA |
 |
Eli Lilly and Company
LLY
|
$ 1 143.12 | 0.02 % | $ 1.03 T | NYSE,SPB | USA |
 |
Lipocine
LPCN
|
$ 2.07 | 0.98 % | $ 11.3 M | Nasdaq Global Select Market | USA |
 |
Liquidia Corporation
LQDA
|
$ 27.64 | 2.32 % | $ 2.38 B | Nasdaq Capital Market | USA |
|
Larimar Therapeutics
LRMR
|
$ 2.86 | 1.75 % | $ 238 M | Nasdaq Global Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.94 | 9.3 % | $ 10.2 M | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.74 | 0.82 % | $ 632 M | Nasdaq Global Select Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.46 | 1.16 % | $ 2.26 M | Nasdaq Global Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 0.48 | 0.42 % | $ 569 K | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.85 | 0.34 % | $ 25.2 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 493.62 | 0.1 % | $ 11.1 B | Nasdaq Global Select Market,SPB | USA |
 |
MediWound Ltd.
MDWD
|
$ 13.51 | 0.22 % | $ 368 M | Nasdaq Global Select Market |  Israel |
 |
Mesoblast Limited
MESO
|
$ 14.22 | 0.99 % | $ 17.2 B | Nasdaq Global Select Market | Australia |
 |
MacroGenics
MGNX
|
$ 3.77 | 5.31 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
MeiraGTx Holdings plc
MGTX
|
$ 10.92 | 1.2 % | $ 878 M | Nasdaq Global Select Market | USA |
 |
Mirum Pharmaceuticals
MIRM
|
$ 81.43 | 0.07 % | $ 4.09 B | Nasdaq Global Select Market | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.78 | 0.25 % | $ 82.9 M | Nasdaq Global Select Market | Canada |
 |
MannKind Corporation
MNKD
|
$ 3.82 | 0.53 % | $ 1.17 B | Nasdaq Global Market | USA |